Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
03/2007
03/08/2007US20070054904 Phenol derivatives and their use as rotamase inhibitors
03/08/2007US20070054888 Novel substituted diamine derivatives useful as motilin agonists
03/08/2007US20070054883 Use controlling growth of quorum-sensing bacteria, controlling biofilm formation, including biofilm growth; cyclic borate, phosphate or sulfate compounds
03/08/2007CA2620688A1 Heterocyclic compound
03/08/2007CA2620600A1 9-aminocarbonylsubstituted derivatives of glycylcyclines
03/07/2007EP1760103A1 Arylamine polymer and organic thin film transistor
03/07/2007EP1760080A1 Design and synthesis of thiophene derived NLO materials for electro-optic applications
03/07/2007EP1758894A1 Heterocyclic carboxamides with microbiocidal activity
03/07/2007EP1758881A1 Thiophene hydroxamic acid derivatives and their use as hdac inhibitors
03/07/2007EP1758880A1 Hydroxamates, their manufacture and use as pharmaceutical agents
03/07/2007EP1758879A1 Method of manufacturing (s)-n-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine hydrochloride (duloxetine)
03/07/2007EP1758655A2 Tetrahydropyridothiophenes for treating hyperproliferative disorders
03/07/2007EP1758577A2 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
03/07/2007EP1758569A2 Guanylhydrazone salts, compositions, processes of making and methods of using
03/07/2007EP1518859B1 Process for the purification of thiophenes
03/07/2007CN1923797A Pharmaceutical compounds
03/07/2007CN1303065C Ambroxol cysteine analogs salt and their preparation process and use thereof
03/07/2007CN1303063C Diamine derivative, process for producing the same, and bactericide containing the same as active ingredient
03/06/2007US7186836 Thienyl compounds
03/06/2007US7186753 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents
03/06/2007US7186752 Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
03/06/2007US7186743 drugs such as 1 -[4-(aminosulfonyl)phenyl]-8-{[(trifluoromethyl)sulfonyl]amino}-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide, used as antiinflammatory agents, antiarthritic agents, antipyretics or analgesics
03/06/2007US7186735 Vasodilation; cardiovascular disorders; anticoagulants
03/06/2007US7186732 For therapy and prophylaxis of upper airway allergic response, nasal congestion, or allergic rhinitis, dementia, mild cognitive impairment (pre-dementia), cognitive dysfunction, schizophrenia, depression, manic disorders
03/06/2007US7186725 Anti-inflammatory compositions and methods
03/06/2007US7186724 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders
03/06/2007US7186722 active against sensitive and resistant species and against all development stages
03/06/2007US7186719 Antibacterial agents
03/06/2007US7186717 Pyrrolidine derivatives as Factor Xa inhibitors
03/06/2007CA2168319C 4-mercaptobenzoylguanidine derivatives
03/06/2007CA2129159C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
03/01/2007WO2007024860A2 Sulfonamides
03/01/2007WO2006135694A3 Uii-modulating compounds and their use
03/01/2007WO2006081273A8 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroayryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity
03/01/2007CA2611736A1 Benzo[b]furane and benzo[b]thiophene derivatives
03/01/2007CA2602969A1 Sulfonamides
02/2007
02/28/2007EP1758172A1 Organic semiconductor thin film, organic semiconductor device, organic thin film transistor, and organic electro-luminescence element
02/28/2007EP1756193A1 Monomer, oligomer and pi-conjugated polymer compounds, and photovoltaic cells containing same
02/28/2007EP1756082A1 5-morpholinylmethylthiophenyl pharmaceutial compounds as p38 map kinase modulators
02/28/2007EP1756081A1 1,1'-(1,2-ethynediyl)bis-benzene derivatives as ptp 1-b inhibitors
02/28/2007EP1756063A1 Amido compounds and their use as pharmaceuticals
02/28/2007EP1756058A1 Histamine-3 receptor antagonists
02/28/2007EP1343561B1 Serine protease inhibitors
02/28/2007EP1240154B1 Serine protease inhibitors
02/28/2007CN1922172A Substituted heterocyclic compounds and uses thereof
02/28/2007CN1922168A Process for the preparation of enantiomerically pure 1-substituted-3-aminoalcohols
02/28/2007CN1922167A Reactive mesogenic charge transport compounds
02/28/2007CN1921845A Furosemide derivatives as modulators of HM74 and their use for the treatment of inflammation
02/28/2007CN1921170A Organic semiconductor material, organic semiconductor element and field effect transistor using the same
02/28/2007CN1301989C Method for the production of (s)-3-methylamino-1-(thien-2-yl)propan-1-ol
02/28/2007CN1301974C Muller Klaus-helmut
02/28/2007CN1301968C Substituied ureaalkyl urea vitamin A protagonist ii
02/28/2007CN1301964C Inhibitors of alpha 4 mediated cell adhesion
02/27/2007US7183436 Substituted 4-aminocyclohexanols
02/27/2007US7183411 Naphthol, quinoline and isoquinoline-derived urea modulators of vanilloid VR1 receptor
02/27/2007US7183324 2,3,4-substituted cyclopentanones as therapeutic agents
02/27/2007US7183320 For therapy of neoplastic diseases
02/27/2007US7183318 Substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
02/27/2007US7183311 NF-κB inhibitors
02/27/2007US7183310 Compounds for prodrug for bonding, using prostaglandins
02/27/2007US7183297 For therapy of rheumatoid arthritis, osteoarthritis, asthma, psoriasis, eczema, allergic rhinitis, allergic conjunctivitis, adult respiratory distress syndrome, chronic pulmonary inflammation, chronic obstructive pulmonary disease, chronic heart failure, silicosis, endotoxemia, toxic shock syndrome
02/27/2007US7183286 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection
02/27/2007CA2168517C Substituted thiophenylsulfonylureas and -thioureas processes for their preparation, their use as a medicament or diagnostic, and medicament containing them
02/22/2007WO2007021693A2 Transition metal catalyzed cross-coupling of 1-halo-1-haloalkene compounds
02/22/2007WO2007020888A1 Brain/neuronal cell-protecting agent, and therapeutic agent for sleep disorder
02/22/2007WO2007020797A1 (e)-n-monoalkyl-3-oxo-3-(2-thienyl)propenamine and process for producing the same and (e,z)-n-monoalkyl-3-oxo-3-(2-thienyl)propenamine and process for producing the same
02/22/2007US20070043090 Novel Sulfonamides
02/22/2007US20070043077 Aryl-carbaldehyde oxime derivatives and their use as estrogenic agents
02/22/2007CA2619720A1 Process for the preparation of strontium ranelate
02/22/2007CA2618653A1 Brain/neuronal cell-protecting agent and therapeutic agent for sleep disorder
02/22/2007CA2616269A1 (e)-n-monoalkyl-3-oxo-3-(2-thienyl)propenamine and process for producing the same and process for producing (e,z)-n-monoalkyl-3-oxo-3-(2-thienyl) propenamine
02/21/2007EP1754705A2 Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders
02/21/2007EP1754703A2 N-Heterocyclic derivatives as nos inhibitors
02/21/2007EP1753710A1 Process for forming branched composition catalytically by carbon-hydrogen bond activation in a saturated moiety
02/21/2007EP1569924A4 Nf-kb inhibitors
02/21/2007EP1551798B1 Novel sulphones for inhibition of gamma secretase
02/21/2007EP1551797B1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors
02/21/2007EP1519726B1 Utilization of heteroarene carboxamide as dopamine-d3 ligands for the treatment of cns diseases
02/21/2007EP1501508B1 Inhibitors of histone deacetylase
02/21/2007EP1311482B1 Non-imidazole aryloxypiperidines as h3 receptor ligands
02/21/2007CN1918139A Cinnamic amides, process for their preparation, and pharmaceutical compositions containing them
02/21/2007CN1917763A N-(2-(hydroxymethyl) phenyl)-1h-pyrazole-4-carboxamide derivatives and related compounds as microbicidal active ingredients for phyto-protection and the protection of materials
02/21/2007CN1916760A Acid-producing agent, sulfonic acid, sulfonic acid derivative and radiation-sensitive resin composition
02/21/2007CN1915964A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
02/21/2007CN1301253C Pentatomic sulphur heterocyclic compound and its use for preparing medicine for treating preventing diseases related to adiposity
02/20/2007US7179941 N-{3-[3-(2-Chloro-4,5-difluorobenzoyl)ureido]-4-methoxyphenyl}acetamide; treating type 2 diabetes
02/20/2007US7179926 Aryloxyalkylamine NK-1/SSRI inhibitors
02/20/2007US7179922 Chemical compounds
02/20/2007US7179912 Materials and methods to potentiate cancer treatment
02/20/2007US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction
02/20/2007US7179836 Using a thiophene compound; angiogenesis inhibitors; antiproliferative agents
02/20/2007US7179817 For therapy and prophylaxis of peripheral arterial disease such as arteriosclerosis obliterans, thromboangiitis obliterans, Buerger's disease or diabetic neuropathy, sepsis, angiitis, nephritis, pneumonia, stroke, myocardial infarction, edematous state, atherosclerosis, varicosity such as hemorrhoid
02/20/2007US7179800 Cannabinoids
02/20/2007US7179368 Method for desulfurizing thiophene derivatives contained in fuels
02/20/2007CA2263561C Thienopyrimidines
02/15/2007WO2007018459A1 Therapeutic agents
02/15/2007WO2007018439A1 Conducting polymers and uses thereof
02/15/2007WO2007018168A1 Acylguanidine derivative or salt thereof
02/15/2007WO2007017728A2 Novel heterocyclic compounds
02/15/2007WO2007017670A1 Bicyclo[2.2.]hept-7-ylamine derivatives and their uses